Skip to main content
PLOS One logoLink to PLOS One
. 2025 Oct 7;20(10):e0321910. doi: 10.1371/journal.pone.0321910

Sources of successful participant engagement in a public health research study: A focus on a Latino community

Angel Lomeli 1,2,*, Arleth A Escoto 1, Breanna Reyes 1, Kayleigh Kornher 3, Keira Beltran-Murillo 3, Kathia Nuñez 3, Ariel Cohen 3, Maria Linda Burola 1, Isabel Villegas 3, Scarlet Flores 4, Ana Perez-Portillo 4, Norma Porras 4, Melody Torres 3, Linda Salgin 4, Kelli L Cain 2, Nicole A Stadnick 5,6,7, Louise C Laurent 1, Borsika A Rabin 2,7, Marva Seifert 8
Editor: Taiwo Opeyemi Aremu9
PMCID: PMC12503261  PMID: 41056322

Abstract

Background

Latino populations remain vastly underrepresented in clinical and translational research. This study aims to characterize the most common sources of successful participant engagement within our sample.

Methods

Between February 2022 and March 2023, research staff systematically recorded how participants learned about an ongoing study (which we term source of successful participant engagement) designed to co-create and implement a COVID-19 testing program in a U.S./Mexico border community. Demographic characteristics were correlated with each source of participant engagement at the univariate level using a chi-squared test and, if significant, were included in a multinomial logistic regression model to determine the association between participant characteristics and source of participant engagement.

Results

A total of 2836 individuals responded to questions regarding source of participant engagement; the most common responses were: Word of Mouth (32%), Clinic/Provider referral (32%), and Walk Up to the testing site (21%). Males were 35% less likely than female participants to report having heard of the study through their Clinic/Provider compared to Walk Up (p < .01). Participants <18 years of age were 2.78 times as likely compared to individuals >54 years of age to have learned about the study through Word of Mouth compared to Walk Up (p < .01). Compared to Walk Up, participants who lived outside San Ysidro were 2.36 times more likely to be recruited through their Clinic/Provider (p < .01) and 2.11 times more likely through Word of Mouth (p < .01), compared those in San Ysidro. Education and clinical symptoms were not significantly associated with engagement source.

Conclusion

Advancing our understanding of sources of successful participant engagement in marginalized communities is necessary to increase equitable participation in clinical and translational research.

Introduction

Latino populations remain vastly underrepresented in clinical and translational research [1]. Non-Hispanic White Americans comprise 58.4% of the total population yet studies have found that they make up more than 90% of participants in research studies [1–2]. Multiple barriers prevent underserved communities from participating in research studies, including perceived stigma and discrimination, social status, language barriers, misinformation, lack of knowledge and understanding about the research process, legal status, and fear of deportation [3]. As a result, participants from these communities may be reluctant to engage in research studies, compromising both the validity and generalizability of research findings [4]. Populations who are non-English speakers, on average, have a lower educational background, lower socioeconomic status, and work in high-risk occupations, making them more likely to experience worse health outcomes [5]. The inadvertent and systematic exclusion of these vulnerable populations from research not only affects the allocation of health services in underserved communities, further exacerbating poor health outcomes, but also undermines health equity and perpetuates systemic injustices by failing to address the unique needs of these communities, further justifying the need to fully understand the root causes of the disproportionality of representation in research [6].

The COVID-19 pandemic amplified the burden of disease and other social determinants of health among racial and ethnic minority groups [7,8]. For instance, the increased likelihood of being unable to work from home and residing in crowded multi-generational households imposed greater risks for infection and transmission [9]. Ethnic minority groups were also more likely to be hospitalized due to COVID-19 infection compared to non-Hispanic White patients [9,10]. Community-based research has become both an ethical and statistical necessity for understanding healthcare access across diverse populations [11,12]. Located in Southern California, in the county of San Diego, the border city of San Ysidro (SY), a predominantly Latino community where 83% identify as Hispanic/Latino(a), was selected for this study because its population is often underrepresented in research, despite its location at one of the world’s busiest international border crossings and proximity to Tijuana, Mexico. Members of this community are more likely to be exposed to adverse living and social situations associated with poor health outcomes, such as substandard housing and underemployment, with about a third of household incomes falling under $30,000 a year [13–15]. Furthermore, Promotores, known as Spanish-speaking Community Health Workers who help bridge patient care in a culturally relevant manner, play a key role in building trust between residents and healthcare administrators while providing culturally appropriate information [15,16]. In our study, we partnered with these Promotores to recruit participants, leveraging their established relationships and deep understanding of the community. Through the translation of existing knowledge regarding the effectiveness of the use of Promotores, this study sought to characterize sources of participant engagement with the Latino community living among the U.S./Mexico border region. Between February 2022 and March 2023, research staff systematically collected and evaluated the self-reported ways individuals learned about the study. In this paper, we refer to this as a source of participant engagement.

Methods

Study design

Community-driven Optimization of COVID-19 testing to Reach and Engage underserved Areas for Testing Equity, in Women and Children (CO-CREATE) was a two-year research study funded by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) program designed to mitigate disparities experienced by underserved communities by offering no-cost COVID-19 polymerase chain reaction (PCR) testing for children, pregnant persons and their families, and the community. The study sought to understand the most prominent barriers and facilitators for COVID-19 testing and access among traditionally underserved communities during the pandemic. Using that knowledge, the team worked with a community and scientific advisory board to co-create a culturally appropriate COVID-19 testing program. In order to achieve this goal, University of California San Diego (UCSD) partnered with a Federally Qualified Health Center (FQHC) in San Diego and a social change organization, to develop and implement a COVID-19 testing program in the San Ysidro community, one of the most affected areas by COVID-19 in San Diego County [13]. The testing site was located in the parking lot of the FQHC. This was advertised as a no-cost COVID-19 testing site first where patients and community members were invited into the study after testing; consenting and participation in the research study was not a requirement to receive a no-cost COVID-19 test. Implementation and outcomes of the CO-CREATE study have been previously described [13–15]. For this analysis, data collected between February 1, 2022 and March 31, 2023 were used.

Study procedures and variables of interest

The CO-CREATE project offered no-cost, walk-up COVID-19 testing to all community members. The eligibility criteria for enrollment in the study included the ability to provide informed consent, either by the individual or their guardian. There were no other eligibility requirements. Individuals who had already been tested for COVID-19 through the CO-CREATE project were marked as “return” and omitted from this analysis. Individuals who registered to test for COVID-19 were also invited to complete a survey about their demographic and health characteristics and received a 20 USD incentive. Participant characteristics and demographic factors used in the analyses were drawn from this survey. Those who declined to participate in the research study were still eligible to receive a no-cost COVID-19 test.

Study staff asked each person who requested a COVID-19 test how they heard about the CO-CREATE research study. Participant responses were open-ended (i.e., they were not offered a forced choice response menu). Research staff documented and organized each response into different categories. A group of 3–5 study staff regularly met after all of the data were collected to combine free-response answers into categories. Discrepancies were discussed among the team and, if necessary, voted on. The final engagement categories were:

  1. Clinic/Provider Referral: Participants learned about our testing site from clinic staff or their provider.

  2. Community Center: Participants were informed about our testing site through a local community center.

  3. County Helpline: Participants were informed about our testing site through one of the San Diego County helplines, such as 211.

  4. Flyer: Participants came across our printed flyer, which was displayed in public locations in the San Ysidro area, informing them about our testing site. Some locations included public parks, public libraries, local grocery stores, and local post offices.

  5. Highway Billboard: Participants learned about our testing site by seeing one of our displayed highway billboards. Four billboards facing the highway were used for approximately five weeks.

  6. Insurance: Participants were informed about our testing site through their health insurance.

  7. On-site Recruitment: Participants were recruited in person within our testing site by study staff, who approached patients in waiting rooms to inform them about our study.

  8. Online – Internet Search: Participants were looking for a COVID-19 testing site online and came across the CO-CREATE project.

  9. Online – Social Media: Participants found out about our testing site through any form of social media.

  10. School: Participants were informed about our testing site through their child’s school.

  11. Walk Up: Participants saw our testing site and walked up to it.

  12. Word of Mouth: Participants were informed about our testing site through personal contacts, such as friends or family members, not including work, school, or insurance.

  13. Work: Participant was informed about our testing site through their work.

Study staff documented the source of successful participant study engagement in each new participant’s profile. Paid advertising campaigns included digital bus stop signs, local radio segments, and highway billboards. Notably, only the highway billboard recruited a participant, while the other advertising campaigns did not. The frequency of each source of participant engagement is shown in Fig 1.

Fig 1. Frequency of self-reported source of participant engagement (N = 2386).

Fig 1

Gathered from the post-testing survey, participants self-reported sex, ethnicity, age, city, education, and clinical symptoms.

For the symptoms variable, participants were given a list of symptoms in a matrix-style question including fever or chills, cough, shortness of breath or difficulty breathing, lack of energy or general tired feeling, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, feeling sick to your stomach or vomiting, diarrhea, abdominal pain, skin sash, and other (participant would be prompted to fill out “other” if selected). For the purpose of this study, if a participant answered “yes” to at least one of the aforementioned symptoms, they were classified as “symptomatic”.

Ethics

This study received approval from the Institutional Review Board at the University of California San Diego Human Research Protections Program, protocol number 210498. All participants provided informed verbal consent or informed verbal assent from a parent or guardian when appropriate, acknowledging potential risks and the voluntary nature of study participation. Upon participants providing consent or assent, a witness study staff member signed a paper copy of the consent/assent, and the participant was provided a copy of the consent/assent form for their records. Participants who did not provide any form of consent or assent are not part of this study, even if they provided information regarding their source of participant engagement.

Statistical analysis

Descriptive statistics were used to characterize participant demographics and chi-squared tests were used to compare participant demographics among the top three sources of successful participant engagement (Walk Up, Clinic/Provider Referral, and Word of Mouth). A subsequent multinomial logistic regression model was fit to include statistically significant (at p < .05) demographic variables. Walk Up is the outcome reference category for all comparisons.

Results

Demographics

Between February 2022 and March 2023, 2386 unique participants reported their primary source of engagement. Out of those participants, 860 (36%) were recruited through Word of Mouth, 763 (32%) through a referral from their Clinic/Provider, and 495 (21%) by Walk Up. The other identified sources of successful participant study engagement were reported at lower frequencies. See Fig 1 for more details.

Chi-squared analysis

The top three sources of successful participant study engagement, Walk Up, Clinic/Provider, and Word of Mouth, were analyzed through cross-tabulation and chi-squared tests for each associated factor of interest (Table 1). Among the respondents included in this model, 57.7% were female, 90.1% were of Hispanic/Latino(a) ethnicity, and 32.9% were 55 years of age or older. See Table 1 for more details.

Table 1. Distribution of participant demographics by top three source of successful participant engagement.

Variable Walk Up -
495 (23.4%)
Clinic/Provider −763 (36.0%) Word of Mouth – 860 (40.6%) Total -
2118
p
Sex <.01
 Female 282 (57.0%) 502 (65.8%) 438 (50.9%) 1222 (57.7%)
 Male 213 (43.0%) 261 (34.2%) 422 (49.1%) 896 (42.3%)
Ethnicity <.01
 Hispanic 465 (93.9%) 708 (92.8%) 736 (85.6%) 1909 (90.1%)
 Not Hispanic 30 (6.1%) 55 (7.2%) 124 (14.4%) 209 (9.9%)
Age <.01
  < 18 48 (9.7%) 111 (14.6%) 128 (14.9%) 287 (13.6%)
 18-24 34 (6.9%) 43 (5.6%) 109 (12.7%) 186 (8.8%)
 25-34 68 (13.7%) 131 (17.2%) 150 (17.4%) 349 (16.5%)
 35-44 57 (11.5%) 99 (13.0%) 108 (12.6%) 264 (12.5%)
 45-54 93 (18.8%) 122 (16.0%) 120 (14.0%) 335 (15.8%)
  > 54 195 (39.4%) 257 (33.7%) 245 (28.5%) 697 (32.9%)
City <.01
 San Ysidro 226 (45.7%) 203 (26.6%) 233 (27.1%) 662 (31.3%)
 Outside SY 263 (18.7%) 541 (38.4%) 605 (42.9%) 1409 (66.5%)
 Prefer not to say 6 (1.2%) 19 (2.5%) 22 (2.6%) 47 (2.2%)
Education <.01
 No High School 91 (18.4%) 141 (18.5%) 171 (19.9%) 403 (19.0%)
 High School 117 (23.6%) 175 (22.9%) 250 (29.1%) 542 (25.6%)
 University 23 (4.7%) 48 (6.3%) 64 (7.4%) 135 (6.4%)
 Prefer not to say 264 (53.3%) 399 (52.3%) 375 (43.6%) 1038 (49.0%)
Symptoms <.01
 Asymptomatic 283 (57.2%) 401 (52.6%) 547 (63.6%) 1231 (58.1%)
 Symptomatic 212 (42.8%) 362 (47.4%) 313 (36.4%) 887 (41.9%)

Multinomial logistic regression model

Compared to female participants, male participants were 35% less likely to report having heard of the CO-CREATE testing site through their Clinic/Provider compared to Walk Up (OR =.65, 95% CI = [.51,.83], p < .01). Compared to participants who self-identified as Hispanic/Latino(a), those who self-identified as non-Hispanic/Latino(a) were 2.12 times more likely to report having heard of the testing site through Word of Mouth compared to Walk Up (OR = 2.12, CI = [1.37, 3.29], p < .01). Participants aged <18 were 1.93 times more likely to be recruited through their Clinic/Provider (OR = 1.93, CI = [1.29, 2.88], p < .01) and 2.78 times more likely to report having heard of the testing site through Word of Mouth (OR = 2.78, CI = [1.87, 4.14], p < .01) compared to Walk Up, compared to participants aged >54. Participants aged 18–24 were 2.88 times more likely to be recruited through Word of Mouth compared to Walk Up, compared to individuals aged >54 (OR = 2.88, CI = [1.85, 4.49], p < .01). Overall, Word of Mouth is more likely to be a source of study engagement for younger participants. Compared to those who reported living in San Ysidro, participants who lived outside of San Ysidro were 2.36 times more likely to report having heard of the testing site through their Clinic/Provider compared to Walk Up (OR = 2.36, CI = [1.85, 3.02], p < . 01) and 2.11 times more likely to be recruited through Word of Mouth compared to Walk Up (OR = 2.11, CI = [1.66, 2.69], p < .01). Although significant in the chi-squared analysis, education and clinical symptoms were not significant in the full regression model. See Table 2 for more details.

Table 2. Adjusted multinomial logistic regression model comparing predictors and source of recruitment information outcomes, compared to Walk Up.

Variable Category OR: Clinic/Provider p OR: Word of Mouth p
Sex
Female [reference] [reference]
Male 0.65 (0.51, 0.83) <.01 1.13 (0.90, 1.43) .29
Ethnicity
Hispanic [reference] [reference]
Not Hispanic 1.13 (0.70, 1.82) .62 2.12 (1.37, 3.29) <.01
Age
>54 [reference] [reference]
<18 1.93 (1.29, 2.88) <.01 2.78 (1.87, 4.14) <.01
18-24 0.99 (0.60, 1.63) .97 2.88 (1.85, 4.49) <.01
25-34 1.42 (0.99, 2.04) .06 1.83 (1.28, 2.61) <.01
35-44 1.31 (0.89, 1.93) .17 1.40 (0.95, 2.07) .09
45-54 0.96 (0.68, 1.34) .80 1.00 (0.72, 1.42) .96
City
San Ysidro [reference] [reference]
Outside SY 2.36 (1.85, 3.02) <.01 2.11 (1.66, 2.69) <.01
Prefer not to say 4.00 (1.55, 10.32) <.01 3.29 (1.29, 8.38) .01
Education
High School [reference] [reference]
No High School 1.11 (0.76, 1.60) .60 1.06 (0.74, 1.51) .76
University 1.40 (0.80, 2.45) .24 1.37 (0.80, 2.35) .26
Prefer not to say 1.04 (0.77, 1.40) .81 0.73 (0.55, 0.98) .04
Symptoms
Asymptomatic [reference] [reference]
Symptomatic 1.18 (0.93, 1.49) .18 0.80 (0.63, 1.01) .06

Note: Reference category is “Walk Up” for both Clinic/Provider and Word of Mouth comparisons. Statistics are formatted as Odds Ratio (OR) (95% Confidence Interval (CI)).

Discussion

Understanding patterns of successful participant engagement is essential to ensuring clinical and translational research participation among historically marginalized and underrepresented Hispanic/Latino(a) populations. Among the source of participant engagement identified and examined in this study, Word of Mouth (36%) emerged as the most frequently reported source of study engagement, followed by Clinic/Provider referrals (32%), and Walk Up (21%). These sources of participant engagement in our study were similar in their reliance on direct, in-person communication, which is consistent with several other studies [17–19]. This aligns with cultural values deeply ingrained in these communities including personalismo (emphasis on building relationships), respeto (respect), familismo (loyalty to family), and confianza (trust) [16,20]. These cultural principles emphasize the importance of direct, in-person communication as a vital approach for implementing effective and culturally meaningful outreach strategies to serve the needs of these communities. For instance, a community-based study employed in a Mexican-origin population, similar to the current study population, discovered that face-to-face contact with community residents and partnerships with community-based organizations (CBOs) were most effective for the enrollment of participants in their study [17]. Passive recruitment methods/sources (e.g., flyers, word of mouth, and radio advertisements) were examined in previous research, with results emphasizing the greater odds of enrollment among Latino(a) immigrants in behavioral research given these recruitment sources [18]. These findings highlight the significance of Word of Mouth as an important source of recruitment, compared to Walking up, when engaging Latino(a) community members in public health research. Furthermore, our data reveal a notable gender difference in recruitment engagement, with male participants being less likely to report having heard of our testing site from a Clinic/Provider compared to female participants, particularly when compared to Walk Up. This trend may be attributable to the tendency for men to visit their healthcare clinic less frequently compared to women; studies have identified that gender disparity in healthcare, including primary care visits, is linked to factors including fear of diagnosis, mistrust in physicians, and adherence to traditional masculinity beliefs [21,22]. Consequently, men demonstrate lower levels of engagement with their primary care physicians, relative to women [23,24]. Our previous research highlights this trend by demonstrating that male participants were less likely to be vaccinated against COVID-19, suggesting a reduced use of primary and preventative healthcare services compared to female participants [14]. This finding offers insight into the sex gap observed in successful referrals among males and females, highlighting the importance of considering these differences when adopting specific recruitment strategies in future studies.

Sources of participant engagement also varied by age group within our study population. Younger participants (cohorts “<18” and “18-24”), were more than twice as likely to be recruited into our study through Word of Mouth than through Walk Up, compared to those >54 years of age. There are several factors that could contribute to this difference. For instance, younger age groups have been found to have more extensive social networks and engage more actively among a variety of communication platforms (e.g., social media and word of mouth) [25]. In addition, younger age groups may be more inclined to trust recommendations from their peers or family members, making Word of Mouth a more effective recruitment source among this age group compared to the older age groups who have been found to rely on more traditional sources, such as face-to-face interaction, for acquiring information [26]. A study conducted on the role of trust among young adolescents’ decision to vaccinate against human papillomavirus (HPV) reported that their trust in their own mothers was stronger compared to other close/influential members [27]. This also highlights the importance of identifying influential members within social networks of various age groups [28]. By targeting referent individuals, enhanced recruitment and engagement strategies can be more effectively used in future community-based studies.

Leveraging interpersonal networks and healthcare provider relationships is critical, as suggested by our findings, particularly for engaging underserved communities in research, similar in composition to our study sample. Building and establishing trust within the community is also essential to enhancing recruitment and retention in research studies, especially among the Latino and Black communities [19]. Partnering with healthcare clinics and providers remains a notable recruitment strategy, due to the level of trust community members place in their healthcare network, as shown in our previous research [14]. Future studies should focus on identifying alternative recruitment strategies outside of the healthcare network to diversify outreach efforts and ensure representative study populations. Moreover, as the popularity and diversity of social media platforms increase, so does their utility for promoting clinical research [29]. Social media’s increasing presence in our society for locating information demonstrates its potential as an innovative approach for increasing and engaging a broader audience [29]. Tailoring recruitment strategies to align with emerging communication platforms will be important for advancing public health research engagement. It is important to note that our sample was overwhelmingly recruited through traditional methods and sources. A source of participant engagement that did not provide many referrals in our study was the use of highway billboards, with just one participant reporting having heard of the study from a billboard. This finding, however, is not unique. A recruitment-focused study based in Baltimore found that billboards were one of the least effective and most expensive forms of recruitment [30]. Unsurprisingly, participants who lived in San Ysidro were significantly more likely to report Walk Up as their source of study engagement compared to living in a different city.

Limitations and future directions

The primary limitation of our study is self-selection bias, meaning that the individuals represented in our sample are solely those who consented to be a part of our study, omitting individuals who chose to get tested at our site, but declined to participate and consent to the study; 60.8% of unique individuals who tested at our site agreed to also consent and participate in our research study. Further, our study’s temporal context can be considered a limitation due to participant enrollment occurring throughout the height of the COVID-19 pandemic, and specifically for an infectious disease study. However, it is important to consider the value of these data gathered during an unprecedented time, a unique opportunity for similar time periods. Another limitation of this study is the generalizability of different geographical settings. While border communities may differ significantly between other cities, their importance and similarities have not yet been explored extensively. Lastly, the collection of study engagement was a component of the larger CO-CREATE project implemented during the peak of the COVID-19 pandemic, resulting in the lack of standardization during the collection process to minimize the burden imposed on study participants. Future studies should allow for multiple source responses, more specific responses (i.e., breaking down Word of Mouth into more specific categories), and the inclusion of qualitative data to provide context for quantitative results. This will allow for future research engagement efforts to be specifically tailored and culturally responsive for target study populations.

Conclusion

Our study identified Walk Up, Clinic/Provider, and Word of Mouth as the three most successful sources of participant engagement in a COVID-19 testing research study in a U.S./Mexico border community. We observed varying differences in engagement by sex, ethnicity, age, city, education, and clinical symptoms common to historically marginalized and underrepresented groups in clinical and translational research. In order for public health research to become more representative and equitable, enhancing generalizability, future studies are needed to identify the most effective sources of successful participant engagement in diverse community contexts.

Supporting information

S1 File. Spreadsheet of de-identified raw data.

(XLSX)

pone.0321910.s001.xlsx (64.9KB, xlsx)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This study was funded by NIH/NIEHS P42ES010337-20S1, awarded to Drs. Robert Tukey and Louise Laurent. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.

References

  • 1.Ma MA, Gutiérrez DE, Frausto JM, Al-Delaimy WK. Minority Representation in Clinical Trials in the United States: Trends Over the Past 25 Years. Mayo Clin Proc. 2021;96(1):264–6. doi: 10.1016/j.mayocp.2020.10.027 [DOI] [PubMed] [Google Scholar]
  • 2.U.S. Census Bureau. United States profile. 2025. https://data.census.gov/profile/United_States?g=010XX00US
  • 3.Rhodes SD, Alonzo J, Mann-Jackson L, Tanner AE, Vissman AT, Martinez O, et al. Selling the product: Strategies to increase recruitment and retention of Spanish-speaking Latinos in biomedical research. J Clin Transl Sci. 2018;2(3):147–55. doi: 10.1017/cts.2018.314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Redwood S, Gill PS. Under-representation of minority ethnic groups in research--call for action. Br J Gen Pract. 2013;63(612):342–3. doi: 10.3399/bjgp13X668456 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.García AA, Zuñiga JA, Lagon C. A Personal Touch: The Most Important Strategy for Recruiting Latino Research Participants. J Transcult Nurs. 2017;28(4):342–7. doi: 10.1177/1043659616644958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–63. doi: 10.1016/S0140-6736(17)30569-X [DOI] [PubMed] [Google Scholar]
  • 7.Etti M, Fofie H, Razai M, Crawshaw AF, Hargreaves S, Goldsmith LP. Ethnic minority and migrant underrepresentation in Covid-19 research: Causes and solutions. EClinicalMedicine. 2021;36:100903. doi: 10.1016/j.eclinm.2021.100903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tai DBG, Shah A, Doubeni CA, Sia IG, Wieland ML. The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States. Clin Infect Dis. 2021;72(4):703–6. doi: 10.1093/cid/ciaa815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mheidly N, Fares NY, Fares MY, Fares J. Emerging Health Disparities during the COVID-19 Pandemic. Avicenna J Med. 2022;13(1):60–4. doi: 10.1055/s-0042-1759842 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Duong KNC, Le LM, Veettil SK, Saidoung P, Wannaadisai W, Nelson RE, et al. Disparities in COVID-19 related outcomes in the United States by race and ethnicity pre-vaccination era: an umbrella review of meta-analyses. Front Public Health. 2023;11:1206988. doi: 10.3389/fpubh.2023.1206988 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Molassiotis A, Xie YJ, Leung AYM, Ho GWK, Li Y, Leung PH-M, et al. A Community-Based Participatory Research Approach to Developing and Testing Social and Behavioural Interventions to Reduce the Spread of SARS-CoV-2: A Protocol for the “COPAR for COVID” Programme of Research with Five Interconnected Studies in the Hong Kong Context. Int J Environ Res Public Health. 2022;19(20):13392. doi: 10.3390/ijerph192013392 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Caperon L, Saville F, Ahern S. Developing a socio-ecological model for community engagement in a health programme in an underserved urban area. PLoS One. 2022;17(9):e0275092. doi: 10.1371/journal.pone.0275092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stadnick NA, Cain KL, Oswald W, Watson P, Ibarra M, Lagoc R, et al. Co-creating a Theory of Change to advance COVID-19 testing and vaccine uptake in underserved communities. Health Serv Res. 2022;57 Suppl 1(Suppl 1):149–57. doi: 10.1111/1475-6773.13910 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lomeli A, Escoto AA, Reyes B, Burola MLM, Tinoco-Calvillo S, Villegas I, et al. Factors associated with COVID-19 vaccine uptake in a US/Mexico border community: demographics, previous influenza vaccination, and trusted sources of health information. Front Public Health. 2023;11:1163617. doi: 10.3389/fpubh.2023.1163617 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Salgin L, Ayers LO, Burola M-L, Engler A-M, Osuna A, Gay L, et al. Perceived COVID-19 risk and testing experiences in the San Ysidro U.S./Mexico border region. Transl Behav Med. 2023;13(7):432–41. doi: 10.1093/tbm/ibac120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.DeGarmo DS, De Anda S, Cioffi CC, Tavalire HF, Searcy JA, Budd EL, et al. Effectiveness of a COVID-19 Testing Outreach Intervention for Latinx Communities: A Cluster Randomized Trial. JAMA Netw Open. 2022;5(6):e2216796. doi: 10.1001/jamanetworkopen.2022.16796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mendez-Luck CA, Trejo L, Miranda J, Jimenez E, Quiter ES, Mangione CM. Recruitment strategies and costs associated with community-based research in a Mexican-origin population. Gerontologist. 2011;51 Suppl 1(Suppl 1):S94-105. doi: 10.1093/geront/gnq076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mansfield LN, Nagy GA, Solorzano R, Carreño M, Mercado Emerson M, Solis Guzman ML, et al. Targeted Strategies for Recruitment and Engagement of Latinx Immigrants in Longitudinal Biobehavioral Research. Hisp Health Care Int. 2023;21(2):68–77. doi: 10.1177/15404153221083659 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sankaré IC, Bross R, Brown AF, Del Pino HE, Jones LF, Morris DM, et al. Strategies to Build Trust and Recruit African American and Latino Community Residents for Health Research: A Cohort Study. Clin Transl Sci. 2015;8(5):412–20. doi: 10.1111/cts.12273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cortés YI, Duran M, Marginean V, Harris LK, Cazales A, Santiago L, et al. Lessons learned in clinical research recruitment of midlife Latinas during COVID-19. Menopause. 2022;29(7):883–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Gast J, Peak T. “It used to be that if it weren’t broken and bleeding profusely, I would never go to the doctor”: men, masculinity, and health. Am J Mens Health. 2011;5(4):318–31. doi: 10.1177/1557988310377926 [DOI] [PubMed] [Google Scholar]
  • 22.Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38. doi: 10.1186/s12875-016-0440-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.U.S. Department of Health and Human Services. Summary health statistics: National health interview survey. CDC.gov. 2014. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2014_SHS_Table_A-18.pdf [Google Scholar]
  • 24.Nuriddin A, Mooney G, White AIR. Reckoning with histories of medical racism and violence in the USA. Lancet. 2020;396(10256):949–51. doi: 10.1016/S0140-6736(20)32032-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Jong ST, Stevenson R, Winpenny EM, Corder K, van Sluijs EMF. Recruitment and retention into longitudinal health research from an adolescent perspective: a qualitative study. BMC Med Res Methodol. 2023;23(1):16. doi: 10.1186/s12874-022-01802-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mendelson T, Sheridan SC, Clary LK. Research with youth of color in low-income communities: Strategies for recruiting and retaining participants. Res Social Adm Pharm. 2021;17(6):1110–8. doi: 10.1016/j.sapharm.2020.08.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Karafillakis E, Peretti-Watel P, Verger P, Chantler T, Larson HJ. “I trust them because my mum trusts them”: Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France. Vaccine. 2022;40(8):1090–7. doi: 10.1016/j.vaccine.2022.01.028 [DOI] [PubMed] [Google Scholar]
  • 28.Krause J, Croft DP, James R. Social network theory in the behavioural sciences: potential applications. Behav Ecol Sociobiol. 2007;62(1):15–27. doi: 10.1007/s00265-007-0445-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Arigo D, Pagoto S, Carter-Harris L, Lillie SE, Nebeker C. Using social media for health research: Methodological and ethical considerations for recruitment and intervention delivery. Digit Health. 2018;4:2055207618771757. doi: 10.1177/2055207618771757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Tompkins DA, Sides JA, Harrison JA, Strain EC. Recruitment techniques for alcohol pharmacotherapy clinical trials: A cost-benefit analysis. Addict Disord Their Treat. 2015;14(4):211–9. doi: 10.1097/ADT.0000000000000047 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Taiwo Opeyemi Aremu

2 Jun 2025

-->PONE-D-25-11940-->-->Sources of Successful Participant Engagement in a Public Health Research Study: a Focus on a Latino Community-->-->PLOS ONE

Dear Dr. Lomeli,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Taiwo Opeyemi Aremu

Academic Editor

PLOS ONE

Journal requirements: 

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf .

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. Please expand the acronym “NIH/NIEHS” (as indicated in your financial disclosure) so that it states the name of your funders in full.

This information should be included in your cover letter; we will change the online submission form on your behalf.

4. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found.

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

6. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately. These will be automatically included in the reviewers’ PDF.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: No

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: No

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: This is a well-written paper that presents important findings about engaging underrepresented communities in research.

A few points to consider and/or clarify:

1. Did participants know the CO-CREATE site was a research study or were they just looking for a COVID test? The study procedures section (top of p15 describes it at first as a project site but then item 7 refers to it as a study). It also seems to be referred to as a testing site throughout the paper. I can imagine people may have a different propensity to visit the site if they know it is specifically research (vs just looking for a COVID test) for the reasons described in the introduction, and this is really important for the fundamental research question around research engagement. It would also be helpful to present how many participants did not consent to the research, as this is mentioned as a limitation.

2. A little more detail would be helpful on the free response coding methods for participant engagement, how many people were doing the coding? Was it consensus-based, and how were discrepancies handled?

3. Where the regression is described in the methods section, it says Walk Up was the most common response but this contradicts Figure 1 indicating Word of Mouth.

4. In Figure 1, it would be better to reduce the dead space between the y-axis and start of bars so they're not floating so much. Also why is the total in Figure 1 different from the total in Table 1?

5. Was the chi-squared test run using the same level of granularity for each variable as listed in the table? If so, having that level of granularity in variables across 3 categories is bound to produce significance because there are so many combinations and cells that inevitably end up with very small numbers. Consider trying to combine where it makes sense conceptually (e.g., is there something about being from Tijuana vs Chula Vista that critically differentiates people and is important to capture or is it actually just important that they're not from SY?). I also see age wasn't tested, please explain why in the text (or if it was tested and the p-value is just missing because it is included in the regression, consider revisiting the granularity of that variable or testing as a continuous variable).

6. I can appreciate the rigorous modelling approach, but it doesn't seem to align with your stated research goal of characterizing sources of participant engagement. In addition to the characterization, it seems like you're also trying to make stronger statements about how those demographic characteristics interact with the engagement mechanism. For this type of research question and how the introduction is framed, it seems like it would be more meaningful to define participant archetypes/a set of characteristics simultaneously for each effective engagement approach rather than singularly like the regression is doing. A latent class analysis may work better for this and be more straightforward to interpret (and present for the reader, the regression results are a little hard to follow and quite cumbersome with all the levels, since the interpretation of any one variable is dependent not only on the reference for that variable but also all the other variables and respective references in the model, i.e. it's not just 'compared to X reference level' it's 'compared to X reference level when variables A, B, and C are also at X, Y, Z reference levels' which can become a bit unwieldy with a bunch of categorical covariates).

Reviewer #2: Although the study is generally understandable, there are places where descriptions are incomplete or not well explained. My attached file suggests a few of those modifications to improve the understanding of methods and results.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .-->

Reviewer #1: No

Reviewer #2: Yes:  Dr. Alfredo L. Fort

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.-->

Attachment

Submitted filename: PONE-D-25-11940_reviewer-AF.pdf

pone.0321910.s002.pdf (1.6MB, pdf)
PLoS One. 2025 Oct 7;20(10):e0321910. doi: 10.1371/journal.pone.0321910.r002

Author response to Decision Letter 1


2 Sep 2025

Reviewer 1:

Did participants know the CO-CREATE site was a research study or were they just looking for a COVID test? The study procedures section (top of p15 describes it at first as a project site but then item 7 refers to it as a study). It also seems to be referred to as a testing site throughout the paper. I can imagine people may have a different propensity to visit the site if they know it is specifically research (vs just looking for a COVID test) for the reasons described in the introduction, and this is really important for the fundamental research question around research engagement. It would also be helpful to present how many participants did not consent to the research, as this is mentioned as a limitation:

Thank you for bringing this up. The testing site was advertised as a testing site first, and, upon testing, patients were offered participation in our study. While testing site and research study could both be used, since both are true, have modified the language when introducing this for clarity and transparency to the reader. We have also added the proportion of individuals who agreed to be a part of the study (60.8%) to the discussion section, as requested.

A little more detail would be helpful on the free response coding methods for participant engagement, how many people were doing the coding? Was it consensus-based, and how were discrepancies handled?:

This is a good suggestion – more information regarding how we came up with handling the free response engagement methods was added for transparency and replicability.

Where the regression is described in the methods section, it says Walk Up was the most common response but this contradicts Figure 1 indicating Word of Mouth:

Thank you for catching this, we have fixed the incorrect language in the text – Figure 1 is correct.

In Figure 1, it would be better to reduce the dead space between the y-axis and start of bars so they're not floating so much. Also why is the total in Figure 1 different from the total in Table 1?:

The different values in fig 1 and table 1 are due to table 1 describing the top three most common sources (rather than all of the sources identified). We have changed the title of the table to reflect this, since it was not clear before. Regarding the figure format, we agree that it looked awkward before due to the excessive white space – this has been fixed.

Was the chi-squared test run using the same level of granularity for each variable as listed in the table? If so, having that level of granularity in variables across 3 categories is bound to produce significance because there are so many combinations and cells that inevitably end up with very small numbers. Consider trying to combine where it makes sense conceptually (e.g., is there something about being from Tijuana vs Chula Vista that critically differentiates people and is important to capture or is it actually just important that they're not from SY?). I also see age wasn't tested, please explain why in the text (or if it was tested and the p-value is just missing because it is included in the regression, consider revisiting the granularity of that variable or testing as a continuous variable):

Yes, the chi-squares tests were run as shown in Table 1. Regarding age, it was run as a continuous variable at first (was significant at p<.01) but was changed to a categorical variable for ease of interpretability for the table and follow-up analysis. As a categorical variable, it was run and also significant at p <.01 but, as you mentioned, was not included in the Table – this was an error and has been fixed and added to the table. As suggested, city was consolidated into three categories – San Ysidro resident, not a San Ysidro resident, and prefer not to answer.

I can appreciate the rigorous modelling approach, but it doesn't seem to align with your stated research goal of characterizing sources of participant engagement. In addition to the characterization, it seems like you're also trying to make stronger statements about how those demographic characteristics interact with the engagement mechanism. For this type of research question and how the introduction is framed, it seems like it would be more meaningful to define participant archetypes/a set of characteristics simultaneously for each effective engagement approach rather than singularly like the regression is doing. A latent class analysis may work better for this and be more straightforward to interpret (and present for the reader, the regression results are a little hard to follow and quite cumbersome with all the levels, since the interpretation of any one variable is dependent not only on the reference for that variable but also all the other variables and respective references in the model, i.e. it's not just 'compared to X reference level' it's 'compared to X reference level when variables A, B, and C are also at X, Y, Z reference levels' which can become a bit unwieldy with a bunch of categorical covariates):

Thank you for this comment. We agree that a multinomial regression model as a final model might not fully capture specific subgroups that our research question is aiming to look at. We had originally considered a latent class analysis, among many different approaches, as a potential model to use for our analysis. Some other approaches we thought of included reducing the outcome variable to two levels (a more conventional categorical regression model) to make statistcal inferences less cumbersome – which would end up being Clinic/Provider vs. Word of Mouth, the two top methods. However, this would leave out the third most common choice which has a high frequency (495) – something we felt was important to include, especially given the next (fourth) highest response was at 78. When looking at the assumptions and model fit for an LCA, we found that the nature of our dataset showed that the model is not a good fit. For example, when calculating the Bayesian information criterion, we found that its value was lowest for the single class model and increased significantly and linearly as the classes increased from 2-5. Lastly, we have a lot of subgroups among each of the variables of interest (as you had pointed out in an earlier comment). Regarding consolidation, we were able to consolidate the city variable to be a comparison of living in San Ysidro vs. not in San Ysidro since, as you mentioned, the purpose of the study is able to be achieved with this consolidation. The chi-square and logistic regression model were re-run since this change would have changed the statistics – this is reflected in both tables in the manuscript.

Reviewer 2:

This might need a definition, to make it clearer for the reader:

Thank you for pointing this out, while this is explained in the main text, we see why it is not clear in the abstract – this has been rectified.

Where in? The one near San Diego, CA? Needs to be fully introduced.

It would be good to provide general socio-demographic characteristics of the city, so that the reader has an idea of the generic "context" of the study area:

More context and specific demographics were added in order to better introduce the region where the study took place, an important factor in introducing the study setting.

Put the term first in quotations, and then explain what they are in English, for the benefit of the reader:

This is a great point – we put promotores in italics, for uniformity across the paper since they were also used in the discussion when Spanish words were mentioned. We also slightly expanded on the role and model of the promotores for more context.

Important to describe where are the other areas...

Which type?

How far away, what characteristics of this place, etc., needed:

As suggested by another reviewer, we have revised the levels of the city variable to only include San Ysidro resident, non-San Ysidro resident, and prefer not to answer. However, we completely agree that it would be a good idea to include an explanation as to where our variable levels were collected including the possible symptoms that participants could have reported which would have resulted in them being classified as “symptomatic” in this study. This has been added to the methods section.

Important percentage; tricky that there is no answer:

If this is referring to the overall percentage of “prefer not to say”, for instance, they can be found in the fifth column under the total, along with their counts for each subgroup in each variable.

Needs to be put more clearer which is the OR, etc., as narrated in the text:

The title of each column was changed to reflect that they are presenting odds ratios. Also, for more clarity, the note under the table was changed to be more specific to what the comparison is.

compared to...?:

Thank you for catching this – this has been rectified.

Any reasons, given that there were open ended questions asked?:

We are unsure… our discussion after this sentence describes potential explanations backed by other studies, including one that precedes this one, who have shown a low rate of primary care and preventative care for men compared to women.

Also physical aspects such as being out and about at younger ages than at older ages...other possible factors?:

Perhaps, however, the study found that older age participants were actually more likely to walk up to our site, not the other way around.

Decision Letter 1

Taiwo Opeyemi Aremu

22 Sep 2025

<p>Sources of successful participant engagement in a public health research study: a focus on a Latino community

PONE-D-25-11940R1

Dear Dr. Lomeli,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Taiwo Opeyemi Aremu, MD, MPH, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewer #1:

Reviewer #2:

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Thank you for your thoughtful responses and edits. All of my comments have been addressed and I have no further notes.

Reviewer #2: Thanks for submitting the revised manuscript, improving several aspects for readers to easily understand the study and the study to be well and fully described. Please see the attached file for only a few final suggestions to clarify descriptions.

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .-->

Reviewer #1: No

Reviewer #2: Yes:  Dr. Alfredo L. Fort

**********

Attachment

Submitted filename: PONE-D-25-11940_R1_reviewer-AF.pdf

pone.0321910.s004.pdf (2.4MB, pdf)

Acceptance letter

Taiwo Opeyemi Aremu

PONE-D-25-11940R1

PLOS ONE

Dear Dr. Lomeli,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Taiwo Opeyemi Aremu

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Spreadsheet of de-identified raw data.

    (XLSX)

    pone.0321910.s001.xlsx (64.9KB, xlsx)
    Attachment

    Submitted filename: PONE-D-25-11940_reviewer-AF.pdf

    pone.0321910.s002.pdf (1.6MB, pdf)
    Attachment

    Submitted filename: PONE-D-25-11940_R1_reviewer-AF.pdf

    pone.0321910.s004.pdf (2.4MB, pdf)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES